![]() |
Volumn 58, Issue 10, 2015, Pages 2247-2253
|
Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes
|
Author keywords
Antidiabetic agents; Clinical quality; Comparative effectiveness; Glucose lowering therapy; Glycaemic control; HbA1c; Hypoglycaemic agents; Metformin; Pharmacoepidemiology; Type 2 diabetes
|
Indexed keywords
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
EXENDIN 4;
HEMOGLOBIN A1C;
INSULIN;
LIRAGLUTIDE;
METFORMIN;
SULFONYLUREA;
ANTIDIABETIC AGENT;
GLUCOSE BLOOD LEVEL;
SULFONYLUREA DERIVATIVE;
ADD ON THERAPY;
ADULT;
AGED;
ARTICLE;
CHARLSON COMORBIDITY INDEX;
COHORT ANALYSIS;
DENMARK;
DISEASE DURATION;
FEMALE;
GLYCEMIC CONTROL;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
TREATMENT DURATION;
ANALYSIS;
BLOOD;
COMBINATION DRUG THERAPY;
DIABETES MELLITUS, TYPE 2;
GLUCOSE BLOOD LEVEL;
MIDDLE AGED;
TREATMENT OUTCOME;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
METFORMIN;
MIDDLE AGED;
SULFONYLUREA COMPOUNDS;
TREATMENT OUTCOME;
|
EID: 84942192266
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s00125-015-3698-1 Document Type: Article |
Times cited : (30)
|
References (9)
|